SC 13G Filing

Company

Denali Therapeutics Inc.

Filed

December 15, 2017

Accession Number

0000315066-17-002960

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →